Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use for the treatment of bacterial skin infections such as impetigo. Clinical trials have demonstrated its efficacy against certain Gram-positive bacteria including MRSA.
Antibiotics & Antibacterials
Send us your enquiry for Retapamulin. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Retapamulin email us and we will include your contribution on the website.